Information  X 
Enter a valid email address

Micro Focus Int plc (MCRO)

  Print   

Monday 01 March, 2021

Micro Focus Int plc

Total Voting Rights

RNS Number : 7324Q
Micro Focus International plc
01 March 2021
 

01 March 2021

 

 

Micro Focus International plc

 

 

Total Voting Rights

 

In fulfilment of its obligations under DTR 5.6.1 R, Micro Focus International plc (the "Company") notifies the market that, on 28 February 2021, the share capital of the Company consisted of 335,236,083 ordinary shares of 10 pence each and a further 29,554,127 ordinary shares held in Treasury.

 

Therefore, the total number of voting rights in the Company is 335,236,083.  This figure should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

Enquiries:

Micro Focus  Tel: +44 (0)1635 32646

Stephen Murdoch, CEO                                       [email protected]

Brian McArthur-Muscroft, CFO

Ben Donnelly, Investor relations

 

 

Brunswick  Tel: +44 (0) 20 7404 5959

Sarah West    [email protected]

Jonathan Glass 

 

 

 

Notes to Editors:

About Micro Focus

Micro Focus (LSE: MCRO.L, NYSE: MFGP) is a global enterprise software company supporting the technology needs and challenges of the Global 2000.  Our solutions help organizations leverage existing IT investments, enterprise applications and emerging technologies to address complex, rapidly evolving business requirements while protecting corporate information at all times. Our product portfolios are Security, IT Operations Management, Application Delivery Management, Information Management & Governance and Application Modernization & Connectivity. For more information, visit: www.microfocus.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRUPURAWUPGGPG

a d v e r t i s e m e n t